Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from iex and EODHD
Download Data

Arcadia Biosciences Inc Cash Flow Statement 2012 - 2024

This table shows the Cash Flow Statement for Arcadia Biosciences Inc going from 2012 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2012-12-31
Net Income
M -7 -14 -15 -16 -20 -16 -21 -21 -22 -16 2 -2 -7 -6 -21 -28 -14 -17 -11 7 -4 -13 -16 -25 -22 -16 -18 -18 -19 -20 -18 -18 -17 -18 -16 -19 -21 -18 -19 -16 -10 -7 -4 -
Depreciation and Amortization
M 1 0 0 0 0 0 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Non-Cash Items (Other)
M 9 14 12 10 5 -1 -1 1 0 0 -12 -12 -12 -13 -1 -1 0 0 1 0 2 3 3 3 1 0 0 0 0 0 0 0 0 1 0 2 1 1 2 1 1 1 1 -
Operating Cash Flow
M -15 -15 -14 -14 -13 -14 -18 -23 -26 -26 -26 -25 -26 -30 -28 -25 -22 -16 -14 -14 -14 -14 -14 -12 -12 -14 -16 -17 -17 -17 -17 -17 -17 -15 -14 -13 -15 -15 -15 -14 -8 -6 -3 -
Capital Expenditures
M 0 0 0 0 0 0 0 0 -1 -1 -1 -1 -2 -2 -3 -3 -2 -2 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Acquisitions
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - -4 -4 -4 -5 0 13 13 14 18 7 1 1 -3 -6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - -
Investing Cash Flow
M - - - - - - - - -4 -4 -4 -5 0 13 13 14 18 7 1 1 -3 -6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - -
Repayment/Issuance of Debt (Net)
M - 0 -1 -1 -1 -1 -1 0 0 -2 -2 -2 1 3 3 3 0 0 0 0 0 0 -25 -51 -76 -101 -101 -75 -50 -25 16 16 35 35 19 19 -1 -1 - - - - - -
Equity Repurchase (Common, Net)
M 0 0 85 85 0 0 25 25 25 26 1 982 989 988 1,011 35 36 46 48 42 25 25 0 0 10 0 0 0 0 0 26 25 86 86 61 62 0 0 - 0 0 0 0 -
Dividends Paid
M - - - - - - 25 25 25 25 1 991 991 990 990 - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - -
Other Financial Activities
M -5 1 1 -85 0 1 24 25 25 23 -1 1 11 13 3 16 5 5 15 -1 -2 -12 -12 -38 -26 -16 -16 10 0 0 -1 -2 12 10 10 11 29 31 38 41 9 9 3 -
Financing Cash Flow
M -5 1 1 -85 0 1 24 25 25 23 -1 1 11 13 3 16 5 5 15 -1 -2 -12 -12 -38 -26 -16 -16 10 0 0 -1 -2 12 10 10 11 29 31 38 41 9 9 3 -
Exchange Rate Adjustment
M - - - - - - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Beginning Cash
M 7 11 13 23 21 23 21 25 29 36 44 33 16 12 17 13 8 21 15 10 7 7 10 20 9 3 13 8 2 10 27 30 24 63 80 11 17 21 26 1 3 1 8 -
Ending Cash
M 3 7 11 13 23 21 23 21 25 29 36 44 33 16 12 17 13 8 21 15 12 12 7 10 20 9 3 13 8 2 10 27 30 24 63 80 11 17 21 26 1 3 8 8
Stock-Based Compensation
M 1 1 1 1 1 1 1 1 1 2 1 1 2 2 2 3 3 2 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 2 2 1 1 1 1 0 0 - -
Issuance/Purchase of Shares
M 0 0 85 85 0 0 25 25 25 26 1 982 989 988 1,011 35 36 46 48 42 25 25 0 0 10 0 0 0 0 0 26 25 86 86 61 62 0 0 - 0 0 0 0 -
Capital Stock Change
M 0 6 6 11 11 5 5 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Working Capital
M 56 70 80 90 96 99 108 120 138 162 157 132 107 74 71 86 86 88 85 81 90 89 80 71 84 111 149 186 198 201 201 215 233 184 143 90 38 38 25 13 -5 -5 - -
Free Cash Flow
M -15 -15 -14 -14 -13 -14 -18 -24 -27 -27 -27 -26 -28 -33 -31 -28 -25 -17 -15 -14 -14 -14 -14 -12 -12 -14 -16 -17 -17 -17 -17 -18 -18 -15 -14 -13 -15 -15 -15 -14 -8 -6 -3 -

StockViz Staff

September 19, 2024

Any question? Send us an email